https://doi.org/10.55788/2cd54fba
The European Heart Rhythm Association (EHRA) has published a practical guide on ‘How to use digital devices to detect and manage arrhythmias’ during their annual meeting [1]. Prof. Dominik Linz (Maastricht University Medical Center, the Netherlands) reviewed the current state of the art regarding app-based monitoring of AF [2].
Many different wearable devices have been developed in recent years to monitor AF remotely: earlobe sensors, watches, chest belts, armbands, and finger bands. The devices can be divided into electrocardiogram (ECG)-based devices and PPG-based devices. Although PPG-based devices cannot be used to diagnose AF, since this requires ECG-based tools, PPG is a novel technique in cardiology that is highly useful in patients that have already been diagnosed with AF.
Advantages of PPG
Recently, a step-by-step approach to interpret PPG data was published [3]. Prof. Linz explained that PPG is very useful to assess the time spent in AF in patients who have already been diagnosed with AF. The output in waveform, tachogram, and Poincaré plot, which we know from implantable devices, provides data on regularity, frequency, and rate. For example, AF, atrial tachycardia, AV-nodal re-entrant tachycardia, and atrial flutter can be assessed through PPG-based monitoring. Furthermore, PPG recordings may aid physicians to analyse symptom/rhythm correlations. If electrical cardioversion is performed in a patient, PPG-based monitoring can be used to assess rhythm and symptoms before and after the procedure to objectively analyse rhythm/symptoms correlations.
Screening
App-based monitoring can also be useful for screening. Systematic screening through ECG-based devices is recommended in high-risk, older patients, in whom AF is more common. In younger patients without comorbidities, PPG-based devices can be used to exclude AF. Prof. Linz added that digital literacy should be taken into account when wearable devices are considered for AF screening.
Integration in practice
“Physicians need to integrate mobile health data in their clinical workflow,” stated Prof. Linz.
For this purpose, companies have been investing in the identification of meaningful, actionable data, which clinicians can use for their patient management. The Telecheck-AF study collected data on heart rhythm and heart rate on-demand for a pre-specified period before patients received a teleconsultation. This way, physicians could use the collected data directly in their approach for AF management. The study showed that fewer ECGs, Holters, and face-to-face consultations were needed, without increasing the number of emergency department visitations [4].
“App-based monitoring of AF has been evolving in recent years,” concluded Prof. Linz. “Importantly, patient education and engagement are key, since the patient must actively monitor its condition.”
- Svennberg E, et al. EP Europace. 2022;euac038.
- Linz D. Remote app-based monitoring of AF. Atrial fibrillation (AF) and heart failure (HF) in the digital era, EHRA 2022, 3–5 April, Copenhagen, Denmark.
- Van der Velden RMJ, et al. EHJ Digital Health. 2021;2(3):363–373.
- Gawalko M, et al. Europace. 2021;23(7):1003–1015.
Copyright ©2022 Medicom Medical Publishers
Posted on
Previous Article
« First results of the POWER FAST III trial Next Article
Early rhythm-control therapy efficacious in men and women with AF »
« First results of the POWER FAST III trial Next Article
Early rhythm-control therapy efficacious in men and women with AF »
Table of Contents: EHRA 2022
Featured articles
Letter from the Editor
Diagnostics and Prevention
Cardiac magnetic resonance imaging improves prediction of post-MI sudden cardiac death
AI model accurately predicts sudden cardiac death in overall population
AI model accurately discriminates between arrhythmias
Developments in Devices
Conduction system pacing potential alternative for biventricular pacing in heart failure
Left bundle branch area pacing is a feasible technique for HF and bradyarrhythmia
Focus on the efficacy of cardiac resynchronisation therapy in HF plus concomitant AF
RESET: No survival benefit of CRT-defibrillator over CRT-pacemaker in heart failure
Insertable cardiac monitors effective for AF detection in cryptogenic stroke
Updates on Ablation
First results of the POWER FAST III trial
Real-world safety results on pulsed-field ablation with pentaspline catheter
VANISH: Ablation reduces shock burden compared with anti-arrhythmic drug in ventricular tachycardia
Low AF recurrence rates after PVI using pulsed-field ablation
Pulsed-field ablation reduces neurocardiac damage versus cryoballoon ablation
Ultrasound-guided femoral venipuncture reduces complications in catheter ablation
News on Atrial Fibrillation
Sex differences revealed in AF determinants and AF progression
Early rhythm-control therapy efficacious in men and women with AF
Progression in remote app-based monitoring of atrial fibrillation
Other Topics
Benefits of SGLT2 inhibitors may extend beyond HF-associated outcomes
Related Articles
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy